Gallic acid ameliorated impaired glucose and lipid homeostasis in high fat diet-induced NAFLD mice

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Chao, Jung ^a   Huo, Teh Ia ^a,b   Cheng, Hao Yuan ^c   Tsai, Jen Chieh ^d,e   Liao, Jiunn Wang ^f   Lee, Meng Shiou ^g   Qin, Xue Mei ^h   Hsieh, Ming Tsuen ^g   Pao, Li Heng ^i,j   Peng, Wen Huang ^g  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c Health Science and Management   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

^e JEN TEH JUNIOR COLLEGE OF MEDICINE   (Taiwan)

^f NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^g CHINA MEDICAL UNIVERSITY   (Taiwan)

^h SHANXI UNIVERSITY   (China)

ⁱ CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^j NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CHOLINE; GALLIC ACID; GLUCOSE; LIPID;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DRUG BLOOD LEVEL; DRUG EFFICACY; FATTY LIVER; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLYCOLYSIS; HISTOPATHOLOGY; HYPERCHOLESTEROLEMIA; INSULIN RESISTANCE; INTESTINE FLORA; LIPID DIET; LIPID METABOLISM; LIVER PROTECTION; MALE; METABOLOMICS; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PROTON NUCLEAR MAGNETIC RESONANCE; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; COMPLICATION; DRUG EFFECTS; HOMEOSTASIS; LIVER; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY;

ANIMALS; DIET, HIGH-FAT; GALLIC ACID; GLUCOSE; HOMEOSTASIS; HYPERCHOLESTEROLEMIA; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; MALE; METABOLOMICS; MICE; MICE, INBRED C57BL; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY;

EID: 84903388430     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096969     Document Type: Article

References (77)

1. Browning JD, Horton JD (2004) Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114: 147-152. (Pubitemid 39071617)
2. Cusi K (2009) Nonalcoholic fatty liver disease in type 2 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes 16: 141-149.
3. Maheshwari DT, Yogendra Kumar MS, Verma SK, Singh VK, Singh SN (2011) Antioxidant and hepatoprotective activities of phenolic rich fraction of Seabuckthorn (Hippophae rhamnoides L.) leaves. Food Chem Toxicol 49: 2422-2428.
4. Peng CH, Liu LK, Chuang CM, Chyau CC, Huang CN, et al. (2011) Mulberry water extracts possess an anti-obesity effect and ability to inhibit hepatic lipogenesis and promote lipolysis. J Agric Food Chem 59: 2663-2671.
5. Wang SH, Kao MY, Wu SC, Lo DY, Wu JY, et al. (2011) Oral administration of Trapa taiwanensis Nakai fruit skin extracts conferring hepatoprotection from CCl4-caused injury. J Agric Food Chem 59: 3686-3692.
6. Lee JE, Lee BJ, Hwang JA, Ko KS, Chung JO, et al. (2011) Metabolic dependence of green tea on plucking positions revisited: a metabolomic study. J Agric Food Chem 59: 10579-10585.
7. Ma J, Luo XD, Protiva P, Yang H, Ma C, et al. (2003) Bioactive novel polyphenols from the fruit of Manilkara zapota (Sapodilla). J Nat Prod 66: 983-986. (Pubitemid 36909848)
8. Oi Y, Hou IC, Fujita H, Yazawa K (2012) Antiobesity effects of Chinese black tea (Pu-erh tea) extract and gallic acid. Phytother Res 26: 475-481.
9. Hsiang CY, Hseu YC, Chang YC, Kumar KJ, Ho TY, et al. (2013) Toona sinensis and its major bioactive compound gallic acid inhibit LPS-induced inflammation in nuclear factor-kappaB transgenic mice as evaluated by in vivo bioluminescence imaging. Food Chem 136: 426-434.
10. Hsu CL, Yen GC (2007) Effect of gallic acid on high fat diet-induced dyslipidaemia, hepatosteatosis and oxidative stress in rats. Br J Nutr 98: 727-735.
11. Jang A, Srinivasan P, Lee NY, Song HP, Lee JW, et al. (2008) Comparison of hypolipidemic activity of synthetic gallic acid-linoleic acid ester with mixture of gallic acid and linoleic acid, gallic acid, and linoleic acid on high-fat diet induced obesity in C57BL/6 Cr Slc mice. Chem Biol Interact 174: 109-117.
12. Kroes BH, van den Berg AJ, Quarles van Ufford HC, van Dijk H, Labadie RP (1992) Anti-inflammatory activity of gallic acid. Planta Med 58: 499-504. (Pubitemid 23074535)
13. Inoue M, Suzuki R, Sakaguchi N, Li Z, Takeda T, et al. (1995) Selective induction of cell death in cancer cells by gallic acid. Biol Pharm Bull 18: 1526-1530.
14. Punithavathi VR, Stanely Mainzen Prince P, Kumar MR, Selvakumari CJ (2011) Protective effects of gallic acid on hepatic lipid peroxide metabolism, glycoprotein components and lipids in streptozotocin-induced type II diabetic Wistar rats. J Biochem Mol Toxicol 25: 68-76.
15. Niho N, Shibutani M, Tamura T, Toyoda K, Uneyama C, et al. (2001) Subchronic toxicity study of gallic acid by oral administration in F344 rats. Food Chem Toxicol 39: 1063-1070. (Pubitemid 32778624)
16. Nicholson JK, Lindon JC, Holmes E (1999) 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29: 1181-1189.
17. Wang X, Zhang A, Han Y, Wang P, Sun H, et al. (2012) Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease. Mol Cell Proteomics.
18. Holmes E, Loo RL, Stamler J, Bictash M, Yap IK, et al. (2008) Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 453: 396-400. (Pubitemid 351693125)
19. Xuan J, Pan G, Qiu Y, Yang L, Su M, et al. (2011) Metabolomic profiling to identify potential serum biomarkers for schizophrenia and risperidone action. J Proteome Res 10: 5433-5443.
20. Wang X, Wang H, Zhang A, Lu X, Sun H, et al. (2012) Metabolomics study on the toxicity of aconite root and its processed products using ultraperformance liquid-chromatography/electrospray-ionization synapt high-definition mass spectrometry coupled with pattern recognition approach and ingenuity pathways analysis. J Proteome Res 11: 1284-1301.
21. Yang HJ, Choi MJ, Wen H, Kwon HN, Jung KH, et al. (2011) An effective assessment of simvastatin-induced toxicity with NMR-based metabonomics approach. PLoS One 6: e16641.
22. Kim HJ, Kim JH, Noh S, Hur HJ, Sung MJ, et al. (2011) Metabolomic analysis of livers and serum from high-fat diet induced obese mice. J Proteome Res 10: 722-731.
23. Lisec J, Schauer N, Kopka J, Willmitzer L, Fernie AR (2006) Gas chromatography mass spectrometry-based metabolite profiling in plants. Nat Protoc 1: 387-396.
24. McLoughlin GA, Ma D, Tsang TM, Jones DN, Cilia J, et al. (2009) Analyzing the effects of psychotropic drugs on metabolite profiles in rat brain using 1H NMR spectroscopy. J Proteome Res 8: 1943-1952.
25. Bao Y, Zhao T, Wang X, Qiu Y, Su M, et al. (2009) Metabonomic variations in the drug-treated type 2 diabetes mellitus patients and healthy volunteers. J Proteome Res 8: 1623-1630.
26. Wang Y, Holmes E, Tang H, Lindon JC, Sprenger N, et al. (2006) Experimental metabonomic model of dietary variation and stress interactions. J Proteome Res 5: 1535-1542. (Pubitemid 44036127)
27. Rezzi S, Ramadan Z, Fay LB, Kochhar S (2007) Nutritional metabonomics: applications and perspectives. J Proteome Res 6: 513-525. (Pubitemid 46340155)
28. Llorach R, Garcia-Aloy M, Tulipani S, Vazquez-Fresno R, Andres-Lacueva C (2012) Nutrimetabolomic strategies to develop new biomarkers of intake and health effects. J Agric Food Chem 60: 8797-8808.
29. Nicholson JK, Lindon JC (2008) Systems biology: Metabonomics. Nature 455: 1054-1056.
30. Kim HK, Choi YH, Verpoorte R (2011) NMR-based plant metabolomics: where do we stand, where do we go? Trends Biotechnol 29: 267-275.
31. Sheng X, Wang M, Lu M, Xi B, Sheng H, et al. (2011) Rhein ameliorates fatty liver disease through negative energy balance, hepatic lipogenic regulation, and immunomodulation in diet-induced obese mice. Am J Physiol Endocrinol Metab 300: E886-893.
32. Beckonert O, Keun HC, Ebbels TM, Bundy J, Holmes E, et al. (2007) Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc 2: 2692-2703.
33. Xu W, Wu J, An Y, Xiao C, Hao F, et al. (2012) Streptozotocin-Induced Dynamic Metabonomic Changes in Rat Biofluids. J Proteome Res.
34. He Q, Tang H, Ren P, Kong X, Wu G, et al. (2011) Dietary supplementation with l-arginine partially counteracts serum metabonome induced by weaning stress in piglets. J Proteome Res 10: 5214-5221.
35. He Q, Kong X,Wu G, Ren P, Tang H, et al. (2009) Metabolomic analysis of the response of growing pigs to dietary L-arginine supplementation. Amino Acids 37: 199-208.
36. Nicholson JK, Foxall PJ, Spraul M, Farrant RD, Lindon JC (1995) 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal Chem 67: 793-811.
37. Dumas ME, Barton RH, Toye A, Cloarec O, Blancher C, et al. (2006) Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci U S A 103: 12511-12516. (Pubitemid 44267289)
38. Salek RM, Maguire ML, Bentley E, Rubtsov DV, Hough T, et al. (2007) A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol Genomics 29: 99-108. (Pubitemid 46701991)
39. Zhao XJ, Hao F, Huang C, Rantalainen M, Lei H, et al. (2012) Systems responses of rats to mequindox revealed by metabolic and transcriptomic profiling. J Proteome Res 11: 4712-4721.
40. Trygg J, Holmes E, Lundstedt T (2007) Chemometrics in metabonomics. J Proteome Res 6: 469-479. (Pubitemid 46340151)
41. Rolo AP, Teodoro JS, Palmeira CM (2012) Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic Biol Med 52: 59-69.
42. Rajalakshmi K, Devaraj H, Niranjali Devaraj S (2001) Assessment of the no-observed-adverse-effect level (NOAEL) of gallic acid in mice. Food Chem Toxicol 39: 919-922. (Pubitemid 32728332)
43. US Food and Drug Administration (2005) Guidance for Industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers. Center for Drug Evaluation and Research. http://www.fda.gov/cder/Guidance/5541fnl.pdf.
44. Carrola J, Rocha CM, Barros AS, Gil AM, Goodfellow BJ, et al. (2011) Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine. J Proteome Res 10: 221-230.
45. Bjerrum JT, Nielsen OH, Hao F, Tang H, Nicholson JK, et al. (2010) Metabonomics in ulcerative colitis: diagnostics, biomarker identification, and insight into the pathophysiology. J Proteome Res 9: 954-962.
46. Cloarec O, Dumas ME, Trygg J, Craig A, Barton RH, et al. (2005) Evaluation of the orthogonal projection on latent structure model limitations caused by chemical shift variability and improved visualization of biomarker changes in 1H NMR spectroscopic metabonomic studies. Anal Chem 77: 517-526. (Pubitemid 40116831)
47. Zhang L, Ye Y, An Y, Tian Y, Wang Y, et al. (2011) Systems responses of rats to aflatoxin B1 exposure revealed with metabonomic changes in multiple biological matrices. J Proteome Res 10: 614-623.
48. Klein J (2000) Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids. J Neural Transm 107: 1027-1063.
49. Grootveld M, Claxson AW, Chander CL, Haycock P, Blake DR, et al. (1993) High resolution proton NMR investigations of rat blood plasma. Assignment of resonances for the molecularly mobile carbohydrate side-chains of 'acute-phase' glycoproteins. FEBS Lett 322: 266-276. (Pubitemid 23144702)
50. Wang Y, Utzinger J, Saric J, Li JV, Burckhardt J, et al. (2008) Global metabolic responses of mice to Trypanosoma brucei brucei infection. Proc Natl Acad Sci U S A 105: 6127-6132. (Pubitemid 351758410)
51. Laffel L (1999) Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev 15: 412-426.
52. Yuzefovych LV, Musiyenko SI, Wilson GL, Rachek LI (2013) Mitochondrial DNA damage and dysfunction, and oxidative stress are associated with endoplasmic reticulum stress, protein degradation and apoptosis in high fat diet-induced insulin resistance mice. PLoS One 8: e54059.
53. Leighton F, Bergseth S, Rortveit T, Christiansen EN, Bremer J (1989) Free acetate production by rat hepatocytes during peroxisomal fatty acid and dicarboxylic acid oxidation. J Biol Chem 264: 10347-10350. (Pubitemid 19161592)
54. Vinaixa M, Rodriguez MA, Rull A, Beltran R, Blade C, et al. (2010) Metabolomic assessment of the effect of dietary cholesterol in the progressive development of fatty liver disease. J Proteome Res 9: 2527-2538.
55. Gupte AA, Bomhoff GL, Swerdlow RH, Geiger PC (2009) Heat treatment improves glucose tolerance and prevents skeletal muscle insulin resistance in rats fed a high-fat diet. Diabetes 58: 567-578.
56. Lee WM, McLeod L, Martin K, Emerson DL, Galbraith RM (1987) Antibodies to polymerized human serum albumin in acute and chronic liver disease. Hepatology 7: 906-912. (Pubitemid 17139240)
57. Samuel VT, Shulman GI (2012) Mechanisms for insulin resistance: common threads and missing links. Cell 148: 852-871.
58. Miyazaki T, Matsuzaki Y (2012) Taurine and liver diseases: a focus on the heterogeneous protective properties of taurine. Amino Acids.
59. Waterfield CJ, Turton JA, Scales MD, Timbrell JA (1991) Taurine, a possible urinary marker of liver damage: a study of taurine excretion in carbon tetrachloride-treated rats. Arch Toxicol 65: 548-555.
60. Timbrell JA, Waterfield CJ (1996) Changes in taurine as an indicator of hepatic dysfunction and biochemical perturbations. Studies in vivo and in vitro. Adv Exp Med Biol 403: 125-134. (Pubitemid 26365192)
61. Brand HS, Jorning GG, Chamuleau RA (1998) Changes in urinary taurine and hypotaurine excretion after two-thirds hepatectomy in the rat. Amino Acids 15: 373-383. (Pubitemid 29012055)
62. Choi CS, Kim YB, Lee FN, Zabolotny JM, Kahn BB, et al. (2002) Lactate induces insulin resistance in skeletal muscle by suppressing glycolysis and impairing insulin signaling. Am J Physiol Endocrinol Metab 283: E233-240. (Pubitemid 34827437)
63. Melis GC, ter Wengel N, Boelens PG, van Leeuwen PA (2004) Glutamine: recent developments in research on the clinical significance of glutamine. Curr Opin Clin Nutr Metab Care 7: 59-70. (Pubitemid 40348185)
64. Poeze M, Luiking YC, Breedveld P, Manders S, Deutz NE (2008) Decreased plasma glutamate in early phases of septic shock with acute liver dysfunction is an independent predictor of survival. Clin Nutr 27: 523-530.
65. Mehta K, Van Thiel DH, Shah N, Mobarhan S (2002) Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. Nutr Rev 60: 289-293. (Pubitemid 35025794)
66. Lever M, Slow S (2010) The clinical significance of betaine, an osmolyte with a key role in methyl group metabolism. Clin Biochem 43: 732-744.
67. Song Z, Deaciuc I, Zhou Z, Song M, Chen T, et al. (2007) Involvement of AMP-activated protein kinase in beneficial effects of betaine on high-sucrose diet-induced hepatic steatosis. Am J Physiol Gastrointest Liver Physiol 293: G894-902. (Pubitemid 47610419)
68. Abdelmalek MF, Angulo P, Jorgensen RA, Sylvestre PB, Lindor KD (2001) Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study. Am J Gastroenterol 96: 2711-2717.
69. Klein MS, Dorn C, Saugspier M, Hellerbrand C, Oefner PJ, et al. (2011) Discrimination of steatosis and NASH in mice using nuclear magnetic resonance spectroscopy. metabolomics 7: 237-246.
70. Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, et al. (2007) Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res 6: 546-551. (Pubitemid 46340158)
71. Tian Y, Zhang L, Wang Y, Tang H (2012) Age-related topographical metabolic signatures for the rat gastrointestinal contents. J Proteome Res 11: 1397-1411.
72. Li H, Zhou M, Zhao A, Jia W (2009) Traditional Chinese medicine: balancing the gut ecosystem. Phytother Res 23: 1332-1335.
73. Bialonska D, Ramnani P, Kasimsetty SG, Muntha KR, Gibson GR, et al. (2010) The influence of pomegranate by-product and punicalagins on selected groups of human intestinal microbiota. Int J Food Microbiol 140: 175-182.
74. Knip M, Douek IF, Moore WP, Gillmor HA, McLean AE, et al. (2000) Safety of high-dose nicotinamide: a review. Diabetologia 43: 1337-1345.
75. Commission E (2002) Opinion of the Scientific Committee on Food on the Upper Tolerable Intake of nicotinic acid and nicotinamide (niacin). European Commission.
76. Ringeissen S, Connor SC, Brown HR, Sweatman BC, Hodson MP, et al. (2003) Potential urinary and plasma biomarkers of peroxisome proliferation in the rat: identification of N-methylnicotinamide and N-methyl-4-pyridone-3-carboxamide by 1H nuclear magnetic resonance and high performance liquid chromatography. Biomarkers 8: 240-271. (Pubitemid 37184381)
77. Eriksson L JE, Kettaneh-Wold N, Trygg J, Wikstrom C, Wold S (2006). Multi-and megavariate data analysis part I: basic principles and applications. Umea: Umetrics. 307.